ImageneBio, Inc. (IMA) Stock Price, Financials & Summary | drillr

Skip to content

Sign in Sign up

Price chart

Aug 19Aug 24Aug 27Sep 1Sep 4Sep 10Sep 15Sep 18

Key dataSep 18, 2026

Open$5.19

From 52W high−46.30%

Volume34625.00

Market cap$53.58M

P/E (TTM)—

P/S (TTM)—

Div yield—

Key dataSep 18, 2026

Open

$5.19

From 52W high

−46.30%

Volume

34625.00

Market cap

$53.58M

ValuationView details →

P/E (Fwd)

—

EV/EBITDA

1.5x

P/E (TTM)

—

RSI (14)

48.8

MomentumView details →

1D Return

−5.98%

YTD Return

−24.64%

ValuationView details →

P/E (Fwd)

—

P/E (TTM)

—

EV/EBITDA

1.5x

EV/Sales

—

P/S (TTM)

—

P/B (TTM)

0.4x

ProfitabilityView details →

Gross Margin

—

Net Margin

—

EBITDA Margin

—

ROE (TTM)

−36.94%

ROA (TTM)

−34.52%

Asset Turnover

0.00x

GrowthView details →

Revenue YoY

—

EPS YoY

−3.37%

FCF YoY

−97.84%

Revenue CAGR 3Y

−62.86%

EPS CAGR 3Y

+76.21%

EBITDA YoY

−28.10%

MomentumView details →

1D Return

−5.98%

YTD Return

−24.64%

1Y Return

−36.97%

RSI (14)

48.8

vs 50D SMA

−5.44%

vs 200D SMA

−12.61%

Capital & dividendView details →

Debt/Equity

0.01x

Current Ratio

21.47x

Quick Ratio

21.47x

Div Yield

—

Div Rate

—

Div Growth 1Y

—

EarningsView details →

EPS (Actual)

−$0.63

EPS Surprise

35.50%

Beats (12Q)

9/12

Next Q EPS Est

−$0.80

Avg Surprise (4Q)

−10.26%

Rev Surprise

—

Financials snapshotView financials →

Revenue (TTM)

0.00

Net Income (TTM)

−52.48M

Op. CF (TTM)

−57.73M

Next earningsNov 11, 2026 →

Latest newsMore news →

ImageneBio, Inc. reported its Q2 2026 financial results, with zero revenue, a net loss of $10.2 million, and a diluted loss per share of $0.63.47d ago

Similar companies

Kezar Life Sciences, Inc.KZR Coeptis Therapeutics, Inc.COEP Dogwood Therapeutics, Inc.DWTX Tevogen Bio Holdings Inc.TVGN Elicio Therapeutics, Inc.ELTX NOMAD Power Solutions, Inc.NMAD Find similar companies →

Latest newsMore news →

ImageneBio, Inc. reported its Q2 2026 financial results, with zero revenue, a net loss of $10.2 million, and a diluted loss per share of $0.63.47d ago